Figure 7. LINC01198 induces temozolomide resistance in glioma patients. (A) Recurrent glioma patients were divided into the LINC01198High group and LINC01198Low group according to the result of qRT-PCR. (B) Comparison of overall survival curves for temozolomide-treated patients with high LINC01198 expression and those with low LINC01198 expression.